187 related articles for article (PubMed ID: 32371897)
21. A synthetic mitochondrial-based vector for therapeutic purposes.
Renteln M
Med Hypotheses; 2018 Aug; 117():28-30. PubMed ID: 30077190
[TBL] [Abstract][Full Text] [Related]
22. Packaging of the Coenzyme Q
Yamada Y; Burger L; Kawamura E; Harashima H
Biol Pharm Bull; 2017; 40(12):2183-2190. PubMed ID: 29199241
[TBL] [Abstract][Full Text] [Related]
23. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
24. Rapid identification of a novel complex I MT-ND3 m.10134C>A mutation in a Leigh syndrome patient.
Miller DK; Menezes MJ; Simons C; Riley LG; Cooper ST; Grimmond SM; Thorburn DR; Christodoulou J; Taft RJ
PLoS One; 2014; 9(8):e104879. PubMed ID: 25118196
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial respiratory chain enzyme assay and DNA analysis in peripheral blood leukocytes for the etiological study of Chinese children with Leigh syndrome due to complex I deficiency.
Ma YY; Wu TF; Liu YP; Wang Q; Li XY; Zhang Y; Song JQ; Wang YJ; Yang YL
Mitochondrial DNA; 2013 Feb; 24(1):67-73. PubMed ID: 22947169
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver.
Yamada Y; Nakamura K; Abe J; Hyodo M; Haga S; Ozaki M; Harashima H
J Control Release; 2015 Sep; 213():86-95. PubMed ID: 26160304
[TBL] [Abstract][Full Text] [Related]
27. Effect of thyroid hormone on mitochondrial properties and oxidative stress in cells from patients with mtDNA defects.
Menzies KJ; Robinson BH; Hood DA
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C355-62. PubMed ID: 19036942
[TBL] [Abstract][Full Text] [Related]
28. NDUFA2 complex I mutation leads to Leigh disease.
Hoefs SJ; Dieteren CE; Distelmaier F; Janssen RJ; Epplen A; Swarts HG; Forkink M; Rodenburg RJ; Nijtmans LG; Willems PH; Smeitink JA; van den Heuvel LP
Am J Hum Genet; 2008 Jun; 82(6):1306-15. PubMed ID: 18513682
[TBL] [Abstract][Full Text] [Related]
29. Fulminant neurological deterioration in a neonate with Leigh syndrome due to a maternally transmitted missense mutation in the mitochondrial ND3 gene.
Leshinsky-Silver E; Lev D; Tzofi-Berman Z; Cohen S; Saada A; Yanoov-Sharav M; Gilad E; Lerman-Sagie T
Biochem Biophys Res Commun; 2005 Aug; 334(2):582-7. PubMed ID: 16023078
[TBL] [Abstract][Full Text] [Related]
30. A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia.
Sarzi E; Brown MD; Lebon S; Chretien D; Munnich A; Rotig A; Procaccio V
Am J Med Genet A; 2007 Jan; 143A(1):33-41. PubMed ID: 17152068
[TBL] [Abstract][Full Text] [Related]
31. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
[TBL] [Abstract][Full Text] [Related]
32. [Mitochondrial respiratory chain complex I deficiency due to 10191T>C mutation in ND3 gene].
Liu YP; Ma YY; Wu TF; Wang Q; Kong QP; Wei XQ; Zhang Y; Song JQ; Chang XZ; Zhang YH; Xiao JX; Yang YL
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):561-6. PubMed ID: 22898272
[TBL] [Abstract][Full Text] [Related]
33. [Targeting mitochondria: innovation from mitochondrial drug delivery system (DDS) to mitochondrial medicine].
Yamada Y; Harashima H
Yakugaku Zasshi; 2012; 132(10):1111-8. PubMed ID: 23037696
[TBL] [Abstract][Full Text] [Related]
34. Heteroplasmic Mutant Load Differences in Mitochondrial DNA-Associated Leigh Syndrome.
Na JH; Lee YM
Pediatr Neurol; 2023 Jan; 138():27-32. PubMed ID: 36335839
[TBL] [Abstract][Full Text] [Related]
35. A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality.
Crimi M; Papadimitriou A; Galbiati S; Palamidou P; Fortunato F; Bordoni A; Papandreou U; Papadimitriou D; Hadjigeorgiou GM; Drogari E; Bresolin N; Comi GP
Pediatr Res; 2004 May; 55(5):842-6. PubMed ID: 14764913
[TBL] [Abstract][Full Text] [Related]
36. Impaired complex I assembly in a Leigh syndrome patient with a novel missense mutation in the ND6 gene.
Ugalde C; Triepels RH; Coenen MJ; van den Heuvel LP; Smeets R; Uusimaa J; Briones P; Campistol J; Majamaa K; Smeitink JA; Nijtmans LG
Ann Neurol; 2003 Nov; 54(5):665-9. PubMed ID: 14595656
[TBL] [Abstract][Full Text] [Related]
37. The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.
Kanabus M; Fassone E; Hughes SD; Bilooei SF; Rutherford T; Donnell MO; Heales SJR; Rahman S
J Inherit Metab Dis; 2016 May; 39(3):415-426. PubMed ID: 27080638
[TBL] [Abstract][Full Text] [Related]
38. Metabolic Signature of MELAS/Leigh Overlap Syndrome in Patient-specific Induced Pluripotent Stem Cells Model.
Hattori T; Hamazaki T; Kudo S; Shintaku H
Osaka City Med J; 2016 Dec; 62(2):69-76. PubMed ID: 30721581
[TBL] [Abstract][Full Text] [Related]
39. MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion.
Yamada Y; Akita H; Kamiya H; Kogure K; Yamamoto T; Shinohara Y; Yamashita K; Kobayashi H; Kikuchi H; Harashima H
Biochim Biophys Acta; 2008 Feb; 1778(2):423-32. PubMed ID: 18054323
[TBL] [Abstract][Full Text] [Related]
40. Targeting the mitochondrial genome via a dual function MITO-Porter: evaluation of mtDNA levels and mitochondrial function.
Yamada Y; Harashima H
Methods Mol Biol; 2015; 1265():123-33. PubMed ID: 25634272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
